Compare NEXR & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEXR | BJDX |
|---|---|---|
| Founded | 2021 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 953.3K | 865.6K |
| IPO Year | 2021 | 2021 |
| Metric | NEXR | BJDX |
|---|---|---|
| Price | $1.04 | $0.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 247.5K | ★ 1.1M |
| Earning Date | 08-14-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 86.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $249,040.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $0.63 |
| 52 Week High | $5.28 | $7.00 |
| Indicator | NEXR | BJDX |
|---|---|---|
| Relative Strength Index (RSI) | 33.54 | 42.44 |
| Support Level | $0.23 | $0.82 |
| Resistance Level | $1.95 | $1.06 |
| Average True Range (ATR) | 0.16 | 0.07 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 8.56 | 25.45 |
Nexera Technologies Ltd focuses on homeland security technologies, artificial intelligence-driven solutions, and detection systems through its subsidiaries and strategic collaborations. The company collaborates with technology partners to distribute and promote new systems such as 3D imaging and electromagnetic threat detection tools, autonomous security technologies, and multi-layered security ecosystems for critical infrastructure and high-traffic venues.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.